Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5233316 | 6241987 | I | 5233316-X | 20050201 | 20070124 | 20070206 | EXP | 2006S1011842 | MYLAN PHARMACEUTICALS INC | 51 | YR | M | N | 225 | LBS | 20070205 | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5233316 | 1008128544 | PS | FENTANYL TRANSDERMAL SYSTEM | 1 | TRANSDERMAL | 75 UG/HR; EVERY 3 DAYS; TRANSDERMAL | D | D | 6P0113 | 20080801 | 76258 |
5233316 | 1008165944 | C | ENOXAPARIN SODIUM | 1 | |||||||
5233316 | 1008165945 | C | WARFARIN SODIUM | 1 | |||||||
5233316 | 1008165946 | C | LEVOTHYROXINE SODIUM | 1 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5233316 | 1008128544 | BACK INJURY |
Outcome of event
Event ID | OUTC COD |
---|---|
5233316 | RI |
Reactions reported
Event ID | PT |
---|---|
5233316 | DRUG EFFECT DECREASED |
5233316 | HEADACHE |
5233316 | LETHARGY |
5233316 | MALAISE |
5233316 | NAUSEA |
5233316 | PAIN |
5233316 | PHARMACEUTICAL PRODUCT COMPLAINT |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
5233316 | CSM |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5233316 | 1008128544 | 20050201 |